Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.905 USD | +8.24% | -3.03% | -86.96% |
Apr. 11 | Baird Trims Amylyx Pharmaceuticals' Price Target to $3 From $4, Maintains Neutral Rating | MT |
Apr. 10 | Transcript : Amylyx Pharmaceuticals, Inc. - Special Call |